rs786204576
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_001164508.2(NEB):c.3987+1_3987+2delinsTG variant causes a splice donor change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 31)
Consequence
NEB
NM_001164508.2 splice_donor
NM_001164508.2 splice_donor
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.53
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.0041832826 fraction of the gene. Cryptic splice site detected, with MaxEntScore 3.3, offset of 17, new splice context is: tagGTgaag. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in inframe change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-151674475-AC-CA is Pathogenic according to our data. Variant chr2-151674475-AC-CA is described in ClinVar as [Likely_pathogenic]. Clinvar id is 188944.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEB | NM_001164507.2 | c.3987+1_3987+2delinsTG | splice_donor_variant | ENST00000427231.7 | NP_001157979.2 | |||
NEB | NM_001164508.2 | c.3987+1_3987+2delinsTG | splice_donor_variant | ENST00000397345.8 | NP_001157980.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.3987+1_3987+2delinsTG | splice_donor_variant | 5 | NM_001164508.2 | ENSP00000380505 | P5 | |||
NEB | ENST00000427231.7 | c.3987+1_3987+2delinsTG | splice_donor_variant | 5 | NM_001164507.2 | ENSP00000416578 | A2 | |||
NEB | ENST00000409198.5 | c.3987+1_3987+2delinsTG | splice_donor_variant | 5 | ENSP00000386259 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Nemaline myopathy 2 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 18, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 188944). Disruption of this splice site has been observed in individuals with nemaline myopathy (PMID: 25205138). Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. This sequence change affects a splice site in intron 36 of the NEB gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). - |
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | Aug 27, 2014 | - - |
Nemaline myopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 25, 2022 | Variant summary: NEB c.3987+1_3987+2delinsTG is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: 4/4 predict the variant abolishes a 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele, which consists of two single nucleotide changes in cis (c.3987+1G>T and c.3987+2T>G), was found at a frequency of 1.8e-05 in 280626 control chromosomes (gnomAD v2.1). The variant c.3987+1_3987+2delinsTG (also described as c.3987+1_3987+2inv) has been reported in the literature in multiple families / individuals affected with Nemaline Myopathy 2 (Lehtokari_2006, Lehtokari_2014, Ravenscroft_2020). These data indicate that the variant is likely to be associated with the disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Another variant affecting the same splice site was also reported in multiple affected individuals (Lehtokari_2014). Three ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 01, 2015 | The c. 3987+1_3987+2delGTinsTG splice site variant in the NEB gene destroys the canonical splice donor site of intron 36. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. The c.3987+1_3987_2delGTinsTG was previously reported, using alternative nomenclature, in a family with nemaline myopathy, although a second pathogenic variant in NEB was not identified (Lehtokari et al., 2006). The c.3987+1_3987+2delGTinsTG variant was not observed in approximately 6,000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Additionally, other pathogenic splice site variants in the NEB gene have been reported in the Human Gene Mutation Database in association with nemaline myopathy (Stenson et al., 2014). Therefore, we interpret c.3987+1_3987+2delGTinsTG as a pathogenic variant. - |
Arthrogryposis multiplex congenita 6 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 16, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at